Kobialka, P., Sabata, H., Vilalta, O., Gouveia, L., Angulo-Urarte, A., Muixi, L., . . . Graupera, M. (2022). The onset of PI3K-related vascular malformations occurs during angiogenesis and is prevented by the AKT inhibitor miransertib.
Citación estilo ChicagoKobialka, P., et al. The Onset of PI3K-related Vascular Malformations Occurs During Angiogenesis and Is Prevented By the AKT Inhibitor Miransertib. 2022.
Cita MLAKobialka, P., et al. The Onset of PI3K-related Vascular Malformations Occurs During Angiogenesis and Is Prevented By the AKT Inhibitor Miransertib. 2022.
Precaución: Estas citas no son 100% exactas.